169 related articles for article (PubMed ID: 19074174)
1. Antiribosomal-P protein antibodies in a patient with systemic lupus erythematosus and non-Hodgkin's lymphoma: more than coincidental finding?
Miljic P; Bonaci-Nikolic B; Colovic N; Terzic T; Colovic M
Lupus; 2009 Jan; 18(1):81-5. PubMed ID: 19074174
[TBL] [Abstract][Full Text] [Related]
2. Association of cerebrospinal fluid anti-ribosomal p protein antibodies with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus.
Hirohata S; Arinuma Y; Takayama M; Yoshio T
Arthritis Res Ther; 2007; 9(3):R44. PubMed ID: 17472755
[TBL] [Abstract][Full Text] [Related]
3. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.
Magalhães MB; da Silva LM; Voltarelli JC; Donadi EA; Louzada-Junior P
Scand J Rheumatol; 2007; 36(6):442-7. PubMed ID: 18092265
[TBL] [Abstract][Full Text] [Related]
4. Antiribosomal P protein antibodies in cerebrospinal fluid are associated with neuropsychiatric systemic lupus erythematosus.
Yoshio T; Hirata D; Onda K; Nara H; Minota S
J Rheumatol; 2005 Jan; 32(1):34-9. PubMed ID: 15630721
[TBL] [Abstract][Full Text] [Related]
5. Anti-ribosomal P protein antibody in human systemic lupus erythematosus up-regulates the expression of proinflammatory cytokines by human peripheral blood monocytes.
Nagai T; Arinuma Y; Yanagida T; Yamamoto K; Hirohata S
Arthritis Rheum; 2005 Mar; 52(3):847-55. PubMed ID: 15751081
[TBL] [Abstract][Full Text] [Related]
6. A close temporal relationship of liver disease to antiribosomal P0 protein antibodies and central nervous system disease in patients with systemic lupus erythematosus.
Yoshio T; Masuyama JI; Minota S; Kaneko N; Iwamoto M; Okazaki H; Mimori A; Takeda A; Kano S
J Rheumatol; 1998 Apr; 25(4):681-8. PubMed ID: 9558169
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies to the ribosomal P proteins in systemic lupus erythematosus.
Reichlin M
Clin Exp Med; 2006 Jun; 6(2):49-52. PubMed ID: 16820990
[TBL] [Abstract][Full Text] [Related]
8. Clinical and diagnostic value of ribosomal P autoantibodies in systemic lupus erythematosus.
Haddouk S; Marzouk S; Jallouli M; Fourati H; Frigui M; Hmida YB; Koubaa F; Sellami W; Baklouti S; Hachicha J; Bahloul Z; Masmoudi H
Rheumatology (Oxford); 2009 Aug; 48(8):953-7. PubMed ID: 19502474
[TBL] [Abstract][Full Text] [Related]
9. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
[TBL] [Abstract][Full Text] [Related]
10. Membrane autoantibodies in systemic lupus erythematosus: a case of autoimmune hemolytic anemia, antiphospholipid antibodies, and transient acquired activated protein C resistance.
Staropoli JF; Van Cott EM; Makar RS
Transfusion; 2008 Nov; 48(11):2435-41. PubMed ID: 18673345
[TBL] [Abstract][Full Text] [Related]
11. Non-Hodgkin's lymphoma in patients with systemic lupus erythematosus.
Papadaki HA; Xylouri I; Katrinakis G; Foudoulakis A; Kritikos HD; Stathopoulos EN; Boumpas DT; Eliopoulos GD
Leuk Lymphoma; 2003 Feb; 44(2):275-9. PubMed ID: 12688345
[TBL] [Abstract][Full Text] [Related]
12. Lymphoma in a patient with systemic lupus erythematosus.
Bernatsky S; Ramsey-Goldman R; Lachance S; Pineau CA; Clarke AE
Nat Clin Pract Rheumatol; 2006 Oct; 2(10):570-4; quiz 575. PubMed ID: 17016483
[TBL] [Abstract][Full Text] [Related]
13. Systemic lupus erythematosus associated with antiribosomal P protein antibody.
Takehara K; Nojima Y; Kikuchi K; Igarashi A; Soma Y; Tsuchida T; Ishibashi Y
Arch Dermatol; 1990 Sep; 126(9):1184-6. PubMed ID: 2204307
[TBL] [Abstract][Full Text] [Related]
14. Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus.
Hoffman IE; Lauwerys BR; De Keyser F; Huizinga TW; Isenberg D; Cebecauer L; Dehoorne J; Joos R; Hendrickx G; Houssiau F; Elewaut D
Ann Rheum Dis; 2009 Mar; 68(3):412-5. PubMed ID: 18930995
[TBL] [Abstract][Full Text] [Related]
15. Late-onset neutropenia following RCHOP chemotherapy in diffuse large B-cell lymphoma.
Lai GG; Lim ST; Tao M; Chan A; Li H; Quek R
Am J Hematol; 2009 Jul; 84(7):414-7. PubMed ID: 19415727
[TBL] [Abstract][Full Text] [Related]
16. Primary non-Hodgkin's lymphoma of the gallbladder diagnosed by laparoscopic cholecystectomy.
Kato H; Naganuma T; Iizawa Y; Kitagawa M; Tanaka M; Isaji S
J Hepatobiliary Pancreat Surg; 2008; 15(6):659-63. PubMed ID: 18987940
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.
Yeo W; Chan TC; Leung NW; Lam WY; Mo FK; Chu MT; Chan HL; Hui EP; Lei KI; Mok TS; Chan PK
J Clin Oncol; 2009 Feb; 27(4):605-11. PubMed ID: 19075267
[TBL] [Abstract][Full Text] [Related]
18. Rituximab and chemotherapy in diffuse large B-cell lymphoma.
Sonet A; Bosly A
Expert Rev Anticancer Ther; 2009 Jun; 9(6):719-26. PubMed ID: 19496708
[TBL] [Abstract][Full Text] [Related]
19. Immunochemotherapy for Bcl-2 and MUM-negative aggressive primary cutaneous B-cell non-Hodgkin's lymphoma.
Colovic N; Jurisic V; Terzic T; Atkinson HD; Colovic M
Arch Dermatol Res; 2009 Oct; 301(9):689-92. PubMed ID: 19495780
[TBL] [Abstract][Full Text] [Related]
20. The course of anticardiolipin antibody levels under immunoadsorption therapy.
Hauser AC; Hauser L; Pabinger-Fasching I; Quehenberger P; Derfler K; Hörl WH
Am J Kidney Dis; 2005 Sep; 46(3):446-54. PubMed ID: 16129206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]